Article
Pharmacokinetics of erythropoietin in genetically anemic mice.
Drug metabolism and disposition: the biological fate of chemicals - 1 Feb 1998
Kato M, Miura K, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y
Abstract excerpt
We examined the pharmacokinetics of recombinant human erythropoietin (rh-EPO) in genetically anemic mice (W/Wv genotype) to clarify its disposition mechanism in hematopoietic injury such as occurs in aplastic anemia. After rh-EPO was administered to W/Wv and control (+/+ genotype) mice once a day for 1 week at different doses, both the hematocrit (Hct) and tissue uptake clearance (CLup) of 125I-rh-EPO by spleen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
